Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
63,000
Employees63,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
63,000
Employees63,000

DHR Key Statistics

Market cap
168.34B
Market cap168.34B
Price-Earnings ratio
49.06
Price-Earnings ratio49.06
Dividend yield
0.54%
Dividend yield0.54%
Average volume
2.14M
Average volume2.14M
High today
$238.50
High today$238.50
Low today
$233.98
Low today$233.98
Open price
$237.30
Open price$237.30
Volume
2.54M
Volume2.54M
52 Week high
$258.23
52 Week high$258.23
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

Danaher(DHR) stock is priced at $238.37, giving the company a market capitalization of 168.34B. It carries a P/E multiple of 49.06 and pays a dividend yield of 53.7%.

During the trading session on 2026-01-11, Danaher(DHR) shares reached a daily high of $238.50 and a low of $233.98. At a current price of $238.37, the stock is +1.9% higher than the low and still -0.1% under the high.

Trading volume for Danaher(DHR) stock has reached 2.54M, versus its average volume of 2.14M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.

DHR News

Barron's 3d
This Stock Is Ready to Put Its Post-Covid Malaise Behind It

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...

This Stock Is Ready to Put Its Post-Covid Malaise Behind It
Simply Wall St 5d
Assessing Danaher Valuation As The Business Refocuses On Life Sciences And Diagnostics

Recent attention on Danaher (DHR) centers on its decision to spin off non core operations and place more emphasis on life sciences, biotechnology tools, and dia...

Assessing Danaher Valuation As The Business Refocuses On Life Sciences And Diagnostics
TipRanks 6d
Danaher price target raised to $250 from $245 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Danaher (DHR) to $250 from $245 and keeps an Outperform rating on the shares. Recovering end...

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
13.8%
Sell
0%

More DHR News

Simply Wall St 6d
Danaher’s Push Into Higher‑Margin Life Sciences Might Change The Case For Investing In DHR

In recent months, Danaher has continued refocusing its portfolio on life sciences and diagnostics, spinning off lower-priority units to emphasize higher-margin...

Danaher’s Push Into Higher‑Margin Life Sciences Might Change The Case For Investing In DHR

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.